propranolol has been researched along with Hyperlipidemias in 28 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of propranolol and proteinuria on the fasting lipoprotein profiles of 33 male renal allograft recipients have been studied." | 7.66 | The role of propranolol therapy and proteinuria in the etiology of post renal transplantation hyperlipidemia. ( Jackson, JM; Lee, HA, 1982) |
| "The metabolic effects of celiprolol, a new beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity and alpha 2-blocking properties, were evaluated in a series of patients with hypertension, both with and without hyperlipidemia." | 5.06 | Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol. ( Cremoncini, M; Dujovne, CA; Gianfranceschi, G; Johnson, B; Montanari, G; Sirtori, CR; Sirtori, M; Vaccarino, V, 1989) |
| "Subjective discomfort caused by nausea and hot, pruritic skin has been described in patients after ingestion of therapeutic dosages of niacin is shown by this study to be alleviated by propranolol HC1." | 5.04 | Preliminary report of the effects of propranolol HCl on the discomfiture caused by niacin. ( Estep, DL; Gay, GR; Rappolt, RT, 1977) |
| " Addition of eugenosedin-A to the high-fat diet resulted in less weight gain and reduced hyperglycaemia, hyperinsulinaemia and hyperlipidaemia." | 3.75 | Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. ( Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN, 2009) |
| "The effects of propranolol and proteinuria on the fasting lipoprotein profiles of 33 male renal allograft recipients have been studied." | 3.66 | The role of propranolol therapy and proteinuria in the etiology of post renal transplantation hyperlipidemia. ( Jackson, JM; Lee, HA, 1982) |
| "The lipophilic beta-adrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients." | 2.71 | Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. ( Droździk, M; Gawrońska-Szklarz, B; Jaroszynska, M; Pawlik, A; Sterna, R; Wójcicki, J, 2003) |
| " In the light of the results obtained, the following conclusions were drawn: 1) hyperlipidemia affects pharmacodynamic properties of lipophilic propranolol and hydrophilic atenolol, 2) a modification of the drug dosage in hyperlipidemia is warranted." | 2.71 | [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol]. ( Droździk, M; Gawrońska-Szklarz, B; Sterna, R; Sulzyc-Bielicka, V; Telatyńska-Smieszek, B; Wójcicki, J, 2004) |
| " Pharmacokinetic parameters were calculated according to the noncompartmental open model." | 2.70 | [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension]. ( Telatyńska-Smieszek, B, 2002) |
| "Propranolol was given orally as a single dose of 80 mg." | 2.69 | Studies on the pharmacokinetics and pharmacodynamics of propranolol in hyperlipidemia. ( Droździk, M; Gawrońska-Szklarz, B; Kutrzeba, J; Sterna, Z; Sulzyc-Bielicka, V; Wójcicki, J, 1999) |
| "Propranolol was given orally as a single dose 80 mg." | 2.68 | [The effect of hypolipemic treatment on the pharmacokinetics of propranolol]. ( Sterna, R, 1997) |
| "Propranolol was given intragastrically at a single dose of 80 mg [corrected]." | 1.30 | [Effect of hydroxylation polymorphism on the concentration of propranolol in the blood of humans with hyperlipidemia]. ( Droździk, M; Gawrońska-Szklarz, B; Kunicki, P; Sitkiewicz, D; Sterna, R; Sulzyc-Bielicka, V; Wójcicki, J, 1999) |
| "Propranolol was used and proved to reduce the fluctuations of total cholesterol." | 1.26 | Intraindividual variability of plasma cholesterol and triglycerides and the effect of propranolol treatment. ( Rühling, K; Schauer, I; Thielmann, K, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (60.71) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Shen, KP | 1 |
| Lin, HL | 1 |
| Hsieh, SL | 1 |
| Kwan, AL | 1 |
| Chen, IJ | 1 |
| Wu, BN | 1 |
| Wójcicki, J | 4 |
| Jaroszynska, M | 1 |
| Droździk, M | 4 |
| Pawlik, A | 1 |
| Gawrońska-Szklarz, B | 4 |
| Sterna, R | 4 |
| Telatyńska-Smieszek, B | 2 |
| Sulzyc-Bielicka, V | 3 |
| Isaza, C | 1 |
| Henao, J | 1 |
| Ramirez, E | 1 |
| Cuesta, F | 1 |
| Cacabelos, R | 1 |
| Spence, JD | 1 |
| Perkins, DG | 1 |
| Kline, RL | 1 |
| Adams, MA | 1 |
| Haust, MD | 1 |
| Dujovne, CA | 2 |
| DeCoursey, S | 1 |
| Krehbiel, P | 1 |
| Jackson, B | 1 |
| Chernoff, S | 1 |
| Jackson, JM | 1 |
| Lee, HA | 1 |
| Bielmann, P | 2 |
| Leduc, G | 2 |
| Davignon, J | 1 |
| Rühling, K | 1 |
| Schauer, I | 1 |
| Thielmann, K | 1 |
| Bagatin, J | 1 |
| Sardelić, S | 1 |
| Pivac, N | 1 |
| Polić, S | 1 |
| Ljutic, D | 1 |
| Rakic, D | 1 |
| Naranca, M | 1 |
| Bojić, L | 1 |
| Kovacić, Z | 1 |
| Rumboldt, Z | 1 |
| Kutrzeba, J | 1 |
| Sterna, Z | 1 |
| Kunicki, P | 1 |
| Sitkiewicz, D | 1 |
| Simons, LA | 1 |
| Myant, NB | 1 |
| Estep, DL | 1 |
| Gay, GR | 1 |
| Rappolt, RT | 1 |
| Chobanian, AV | 1 |
| Sirtori, CR | 1 |
| Johnson, B | 1 |
| Vaccarino, V | 1 |
| Montanari, G | 1 |
| Cremoncini, M | 1 |
| Gianfranceschi, G | 1 |
| Sirtori, M | 1 |
| Metelitsa, VI | 1 |
| Oganov, RG | 1 |
| Grzywa, M | 1 |
| Brook, JG | 1 |
| Marmur, A | 1 |
| Berkovitch, Y | 1 |
| Aviram, M | 1 |
| Whitaker, AN | 1 |
| Bunce, I | 1 |
| Knowles, BR | 1 |
| Richardson, ER | 1 |
| Olefsky, JM | 1 |
| Farquhar, JW | 1 |
| Reaven, GM | 1 |
| Miyahara, M | 1 |
| Ashinaga, T | 1 |
| Morikawa, R | 1 |
| Minemawari, Y | 1 |
| Lipson, MJ | 1 |
| Naimi, S | 1 |
| Proger, S | 1 |
1 review available for propranolol and Hyperlipidemias
| Article | Year |
|---|---|
[Catecholamines and arteriosclerosis].
Topics: Adrenal Glands; Angina Pectoris; Arteriosclerosis; Catecholamines; Depression, Chemical; Epinephrine | 1972 |
11 trials available for propranolol and Hyperlipidemias
| Article | Year |
|---|---|
Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Area Under Curve; Atenolol; Blood Pressure | 2003 |
[Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cross-Over Studies; Female; Humans; Hyperlipidemias; M | 2002 |
[Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Area Under Curve; Atenolol; Blood Pressure; Chrom | 2004 |
Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cholesterol, HDL; Colombia; Female; | 2005 |
Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Female; Humans; Hyperlipidemias; Hypertension; Lipids; L | 1984 |
[The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
Topics: Administration, Oral; Anticholesteremic Agents; Bezafibrate; Chromatography, High Pressure Liquid; D | 1997 |
Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Chlorthalidone; Double-Blind Method; Female; Humans; Hyp | 1998 |
Studies on the pharmacokinetics and pharmacodynamics of propranolol in hyperlipidemia.
Topics: Adult; Anti-Arrhythmia Agents; Area Under Curve; Blood Pressure; Female; Heart Rate; Humans; Hyperli | 1999 |
Preliminary report of the effects of propranolol HCl on the discomfiture caused by niacin.
Topics: Clinical Trials as Topic; Humans; Hyperlipidemias; Nausea; Nicotinic Acids; Propranolol; Pruritus | 1977 |
Effects of metoprolol and propranolol on lipid metabolism.
Topics: Cholesterol; Double-Blind Method; Humans; Hyperlipidemias; Lipid Metabolism; Metoprolol; Propanolami | 1979 |
Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Cholesterol; Chromatography, High Pressure Liq | 1989 |
16 other studies available for propranolol and Hyperlipidemias
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glut | 2009 |
Hemodynamic modification of aortic atherosclerosis. Effects of propranolol vs hydralazine in hypertensive hyperlipidemic rabbits.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Cholesterol; Hemodynamics; Hydralazine; Hyperlipidemias; | 1984 |
The role of propranolol therapy and proteinuria in the etiology of post renal transplantation hyperlipidemia.
Topics: Adolescent; Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Humans; Hyperlipidemias; Kidney | 1982 |
[Selective beta blockaders (metoprolol) versus non selective (propranolol): comparative effects on the composition of lipoprotein fractions and on blood pressure].
Topics: Blood Pressure; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Lip | 1980 |
Intraindividual variability of plasma cholesterol and triglycerides and the effect of propranolol treatment.
Topics: Adult; Cholesterol; Humans; Hyperlipidemias; Individuality; Lipoproteins, HDL; Male; Middle Aged; Pr | 1980 |
[Effect of hydroxylation polymorphism on the concentration of propranolol in the blood of humans with hyperlipidemia].
Topics: Adolescent; Adult; Antihypertensive Agents; Female; Humans; Hydroxylation; Hyperlipidemias; Male; Mi | 1999 |
Cholesterol metabolism in hypertriglyceridaemia and the effects of treatment.
Topics: Adult; Alcohol Drinking; Bile Acids and Salts; Cholesterol; Chylomicrons; Diabetes Complications; Di | 1975 |
The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Calciu | 1990 |
System approach to testing hypotensive drugs for prevention of arterial hypertension.
Topics: Clinical Trials as Topic; Humans; Hydralazine; Hyperlipidemias; Hypertension; Prazosin; Propranolol | 1987 |
Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
Topics: Adult; Body Weight; Growth Hormone; Humans; Hyperlipidemias; Levodopa; Male; Middle Aged; Obesity; P | 1986 |
Platelet adhesion in hyperlipidemic and hypertensive patients.
Topics: Adult; Arteriosclerosis; Atenolol; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinem | 1985 |
Hyperlipidemia in experimental disseminated intravascular coagulation.
Topics: Aminocaproates; Analysis of Variance; Angiotensin II; Animals; Cholesterol; Disseminated Intravascul | 1974 |
Reappraisal of the role of insulin in hypertriglyceridemia.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Diet; Epinephrine; Female; Glucose; Glucose Tolera | 1974 |
Angina pectoris--II.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cholesterol; Cholestyramine Resin; Clofibrate; D | 1971 |
Effect of a combination of propranolol and nicotinic acid on the inhibition of norepinephrine-induced elevations of serum triglyceride, serum glycerol, and plasma free fatty acids in the dog.
Topics: Animals; Cholesterol; Depression, Chemical; Dogs; Drug Antagonism; Drug Synergism; Fatty Acids, None | 1971 |